// App-Quantinova.ai

: Immunogenicity of Two Plasma-Derived FVIII Products and Simoctocog Alfa in Previously Untreated Patients According to F8 Mutation Type

Researchers

Presenter

  • Ri Liesner

Principal Investigators

  • Joris Versteden

  • Shannely Lowndes

  • Larisa Belyanskaya

  • Johannes Oldenburg

  • Anna Pavlova

Medical Centers

  • Haemophilia Comprehensive Care Centre, Great Ormond Street Hospital for Children, London, United Kingdom

  • Octapharma AG, Lachen, Switzerland

  • Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany

Locations

  • United Kingdom

  • Switzerland

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • simoctocog alfa

  • Octanate

  • Wilate

  • Nuwiq

  • FVIII

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved